Congress Calendar


News

Saturday 19.04.2014

  • 15.04.2014 »

    On the front of its Business Day section, the New York Times (4/15, B1, Thomas, Subscription Publication) reports that a small group of the US “population is being asked to shoulder more and more of the cost of expensive treatments for diseases like cancer and hepatitis C, according to a report to be released” today [...]

  • 14.04.2014 »

    The Washington Post (4/14, Dennis) reported a Federal judge is set to rule on Massachusetts Gov. Deval L. Patrick’s recent move “to prohibit the sale of” new opioid painkiller Zohydro (hydrocodone bitartrate) “approved last fall by” the FDA. The issue at the heart of the matter is whether a state can “ban a drug that [...]

  • 10.04.2014 »

    Several outlets on both sides of the Atlantic report on a British study that casts doubt upon the effectiveness of government stockpiles of a pair of medications intended to mitigate future influenza pandemics. The Wall Street Journal (4/10, Plumridge, Subscription Publication) reports on a new meta-analysis that casts doubt on the ability of anti-influenza medications [...]

  • 9.04.2014 »

    In continuing coverage, the New York Times (4/9, Fackler, Pollack, Subscription Publication) reported that “a jury in Louisiana has ordered” a Takeda Pharmaceutical and its American partner, Eli Lilly & Co. “to pay a combined $9 billion in punitive damages over a diabetes drug that has been linked to cancer.” According to the paper, both [...]

  • 8.04.2014 »

    Bloomberg News (4/9, Stohr) reported a US Supreme Court justice “asked generic-drug makers to respond to Teva Pharmaceutical Industries Ltd.” proposal “for perhaps a yearlong delay on competition to its top-selling Copaxone” (glatiramer acetate) multiple-sclerosis medicine. The article noted that the request by Chief Justice John Roberts “comes a week after the court agreed to [...]